Corporate Transparency Act Key Points

By |2024-11-08T13:07:24+00:00November 5, 2024|Resources and Insights|

November 5, 2024 The Corporate Transparency Act (the “CTA”), effective January 1, 2024, is a new federal law that requires many small businesses to make informational filings with the U.S. Treasury Department’s Financial Crimes Enforcement Network(“FinCEN”). We wanted to make you aware of a few key points on the CTA. Additionally, please contact us at [...]

Comments Off on Corporate Transparency Act Key Points

Corporate Transparency Act Information

By |2024-03-19T12:55:00+00:00March 19, 2024|Resources and Insights|

March 19, 2024 The Corporate Transparency Act (the “CTA”), effective January 1, 2024, is a new federal law that requires many small businesses to make informational filings with the U.S. Treasury Department’s Financial Crimes Enforcement Network (“FinCEN”). The CTA is intended to prevent illegal activity through anonymous shell companies by requiring certain privately held entities [...]

Comments Off on Corporate Transparency Act Information

Florida Patient Self-Referral Act Change in Level of Physician Supervision

By |2023-07-24T17:52:29+00:00July 24, 2023|Resources and Insights|

Florida Patient Self-Referral Act Change in Level of Physician Supervision Effective July 1, 2023   The Florida Patient Self-Referral Act of 1992 (the “Florida Act”) prohibits a health care provider from referring a patient for the provision of designated health services or any other health care items or service to an entity in which the [...]

Comments Off on Florida Patient Self-Referral Act Change in Level of Physician Supervision

Expanded Protections for Genetic Information

By |2021-11-22T12:57:59+00:00November 11, 2021|Resources and Insights, Uncategorized|

Direct-to-consumer DNA testing kits such as 23andMe and Ancestry.com allow consumers to learn about their risks of developing certain diseases and investigate their family tree by submitting their DNA sample containing their genetic information.  These tests have become very popular because they are convenient, inexpensive, and easy to use.  However, they also raise privacy concerns [...]

Comments Off on Expanded Protections for Genetic Information

What to do if Your License is Under Investigation

By |2021-11-22T12:58:25+00:00November 11, 2021|Resources and Insights|

What to Do if Your License is Under Investigation When individuals obtain their licenses to practice their healthcare profession, they typically don’t contemplate being the subject of an investigation for possible licensure violations.  As such, they are often unprepared for how to respond when they receive a Notice of Investigation from the Florida Department of [...]

Comments Off on What to do if Your License is Under Investigation

The Impact of New Florida COVID Laws on Healthcare Providers

By |2021-11-22T12:58:49+00:00November 11, 2021|Resources and Insights|

Keeping up with the various federal agency guidance and state mandates regarding COVID-19 can be overwhelming for healthcare providers especially when such guidance often changes daily.  Healthcare providers need to be aware of newly enacted Florida laws regarding COVID-19 which were effective July 1, 2021. Vaccine Passports Section 381.00316, Florida Statutes (“COVID-19 Vaccine Documentation”) prohibits [...]

Comments Off on The Impact of New Florida COVID Laws on Healthcare Providers

Three Keys to Drive a Successful Sale of Your Business

By |2021-10-01T15:12:55+00:00September 18, 2019|Resources and Insights|

Over the years I received many questions about how I was able to successfully sell my business. While there are many components to consider, I believe it boils down to the following three keys: 1. Time -- As Abraham Lincoln once said, “Give me six hours to chop down a tree and I will spend [...]

Comments Off on Three Keys to Drive a Successful Sale of Your Business

A Breakdown of Contractual Limitations on Liability

By |2021-10-01T15:12:59+00:00August 5, 2019|Resources and Insights|

One of the most common negotiating tools is the use of contractual limitations on liability to establish the risk each party undertakes in an agreement. Each party always wants to limit its own risk, while at the same time requiring the other party to maintain full liability. Negotiating these types of limitations of liability provisions [...]

Comments Off on A Breakdown of Contractual Limitations on Liability

Know The Terms Of Your Preferred Equity

By |2021-10-01T15:13:04+00:00July 3, 2019|Resources and Insights|

We are often involved with assisting companies raising capital, and these companies can be at various stages of their business life cycles. For example, a start-up company might be raising capital for a wide variety of reasons (such as hiring a sales force, product development, etc.) and a middle-stage company might be raising capital for [...]

Comments Off on Know The Terms Of Your Preferred Equity

Preparing to Sell a Practice: A Seller-Side Guide for Healthcare Providers

By |2019-06-05T14:23:46+00:00June 5, 2019|Resources and Insights|

The successful sale of a healthcare practice largely depends on business operations during the growth stage of the business. Buyers understand that efficient, compliant operations during the growth stage can lead to profitability and expansion post-transaction. Unfortunately, many practices cut corners to reduce short-term expenses when growing the business. Cutting corners may save money in [...]

Comments Off on Preparing to Sell a Practice: A Seller-Side Guide for Healthcare Providers

What is the Difference between a ROFO and ROFR?

By |2018-08-22T17:32:53+00:00August 22, 2018|Resources and Insights|

A Right of First Offer (“ROFO”) and a Right of First Refusal (“ROFR”) are both contractual obligations that often arise in the context of a lease arrangement or in connection with selling an asset (such as a piece of property).  These provisions restrict the assets held or leased by an owner and benefit the holder [...]

Comments Off on What is the Difference between a ROFO and ROFR?

New Opioid Law

By |2018-07-19T12:07:47+00:00July 19, 2018|Resources and Insights|

On March 19, 2018, Governor Rick Scott signed House Bill 21 into law, which increases the regulation of prescriptions for controlled substances and expands the use of the Florida Prescription Drug Monitoring Program (“PDMP”).   This new law became effective on July 1, 2018. Limits for Prescriptions for Controlled Substances for Treatment for Acute Pain Prescriptions [...]

Comments Off on New Opioid Law
Go to Top